Myopia as a problem of the modern world. Methods of treatment and prevention
DOI:
https://doi.org/10.12775/JEHS.2025.78.57683Keywords
myopia, environment, treatment, atropine, contact lenses, health educationAbstract
Introduction and objective
Sight is one of the most important human senses, which enables proper coordination of the entire body. Short-sightedness is increasingly being called the “scourge” of our time. Prognosis in early 2024 predict that people with myopia problems may represent as much as 35% of humanity. In the research, we want to present the possibilities of treating and preventing short-sightedness, collect those that seem most relevant and effective against the background of today's knowledge.
Abbreviated description of the state of knowledge
Short-sightedness (myopia) is a visual defect in which light rays do not focus properly on the retina, but in front of it. Among the methods of treating and slowing down the progression of myopia, we can identify environmental, pharmacological, optical and surgical methods. Intracular lenses and soft contact lenses are the most frequently used forms of correction. However, at high values of the defect, they may not be effective enough. The choice in such situation is hard contact lenses, which are not always well tolerated by patients. Among the methods confirmed by numerous studies of slowing the progression of myopia still include atropine and orthocorrection. More innovative techniques include DIMS lenses, HAL and red light therapy. However, they require more research to confirm their long-term effectiveness and safety.
Summary
In recent years, myopia has become a worldwide problem. Promising results are provided by recent studies on HAL spectacle lenses, DIMS, MiSight contact lenses and RLRL. Thanks to the large number of treatment methods, the doctor can adjust the treatment that seems to be best for the patient. The development of current therapies, as well as an appropriate lifestyle, are important aspects for the treatment of myopia.
References
1. Czajkowski J. The health-promoting lifestyle of a young individual with myopia. Polish Ophthalmology Review. 2024;21(1): 24-27. Polish
2. Grzybowski A, Koziak M, Tomczak B. Benefits of contact lenses in ophthalmology. Polish Ophthalmology Review. 2024;21(3): 11-14. Polish
3. Zając M. Spectacle optics. Lower Silesian Educational Publishing, 2007. Polish
4. Grzybowski A, Kanclerz P, Tsubota K, Lanca C, Saw SM. A review on the epidemiology of myopia in school children worldwide. BMC Ophthalmol. 2020;20(1):27. https://doi.org/10.1186/s12886-019-1220-0
5. Modjtahedi BS, Abbott RL, Fong DS, Lum F, Tan D. Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children: The Academy’s Task Force on Myopia. Ophthalmology. 2021;128(6): 816-826. https://doi.org/10.1016/j.ophtha.2020.10.040
6. Németh J, Tapasztó B, Aclimandos WA, Kestelyn P, Jonas JB, de Faber JT, et al. Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. Eur J Ophthalmol. 2021;31(3): 853–883. https://doi.org/10.1177/1120672121998960
7. He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA. 2015;314(11): 1142–8. https://doi.org/10.1001/jama.2015.10803
8. Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, Liu YM, et al. IMI - Clinical Management Guidelines Report. Invest Ophthalmol Vis Sci. 2019;60(3): 184-20. https://doi.org/10.1167/iovs.18-25977
9. Cristaldi M, Olivieri M, Pezzino S,Spampinato G, Lupo G, Anfuso CD, et al. Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum. Biomedicines. 2020;8(4): 78 https://doi.org/10.3390/biomedicines8040078
10. Yokoi T, Jonas JB, Shimada N, Nagaoka N, Moriyama M, Yoshida T, et al. Peripapillary Diffuse Chorioretinal Atrophy in Children as a Sign of Eventual Pathologic Myopia in Adults. Ophthalmology. 2016 ;123(8): 1783-1787 https://doi.org/10.1016/j.ophtha.2016.04.029
11. Wu H, Chen W, Zhao F, Zhou Q, Reinach PS, Deng L, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci U S A. 2018;115(30): E7091-E7100. https://doi.org/10.1073/pnas.1721443115
12. Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology 2019;126: 113–124. https://doi.org/10.1016/j.ophtha.2018.05.029
13. Yam JC, Li FF, Xiuhuan Z, Tang SM, Yip BHK, Kam KW, et al. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology. 2020;127(7): 910-919. https://doi.org/10.1016/j.ophtha.2019.12.011
14. Repka MX, Weise KK, Chandler DL, Wu R, Melia M, Manny RE, et al. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. JAMA Ophthalmol. 2023;141(8): 756-765. https://doi.org/10.1001/jamaophthalmol.2023.2855
15. Yam JC, Zhang XJ, Zhang Y, Yip B, Tang F, Wong ES, et al. .Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA. 2023;329(6): 472-481. https://doi.org/10.1001/jama.2022.24162
16. Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123(2): 391-399. https://doi.org/10.1016/j.ophtha.2015.07.004
17. Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, et al. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis JAMA Ophthalmol. 2017;1: 624–630. https://doi.org/10.1001/jamaophthalmol.2017.1091
18. Chung K, Mohidin N, O'Leary DJ. Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res. 2002;42(22): 2555-9. https://doi.org/10.1016/s0042-6989(02)00258-4
19. Adler D, Millodot M. The possible effect of undercorrection on myopic progression in children. Clin Exp Optom. 2006;89(5): 315-21. https://doi.org/10.1111/j.1444-0938.2006.00055.x
20. Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti D, Ng SM, et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2020;1(1): CD004916. https://doi.org/10.1002/14651858.CD004916.pub4
21. Bao J , Huang Y , Li X, Yang A, Zhou F, Wu J, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial .JAMA Ophthalmol. 2022; 140(5): 472-478. https://doi.org/10.1001/jamaophthalmol.2022.0401
22. Lam CSY, Tang WC , Tse DY, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2019;104(3): 363–368. https://doi.org/10.1136/bjophthalmol-2018-313739
23. Guo H, Li X, Zhang X, Wang H, Li J. Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control. Sci. Rep. 2023; 13(1): 3048
24. Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS One. 2023;18(2): e0281816. https://doi.org/10.1371/journal.pone.0281816
25. Maldonado-Codina C, Efron N. Materials of soft contact lenses. Contactology. Vol I. Edra Urban & Partner, Wrocław, 2018. Polish
26. Morgan PB, Woods CA, Tranoudis IG, Efron N, Jones L, Faccia P, et al. International contact lens prescribing in 2023. A report on trends in global contact lens prescribing from our 23rd consecutive annual survey. Contact Lens Spectrum, 2024. Vol. 39:20-22, 24, 26-28
27. T. Grosvenor. Optometry. Urban & Partner, 2011. Polish
28. Myopia control in children and adolescents. CooperVision. URL address: https://coopervision.pl/specjalista/materialy-edukacyjne-dla-specjalistow/kontrola-krotkowzrocznosci-u-dzieci-i-mlodziezy (date: 20.11.2024). Polish
29. Gas Permeable Lens Institute. Contact Lens clinical pearls pocket guide. URL address: https://gpli.info/fitting-guide/ (date: 21.10.2024)
30. Chamberlain P , Peixoto-de-Matos SC , Logan NS, Ngo C, Jones D, Young G. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019;96(8): 556-567. https://doi.org/10.1097/OPX.0000000000001410
31. Gasson A, Morris JA. Contact lenses. A practical guide to proper fitting. Elsevier Urban & Partner, Wrocław, 2014. Polish
32. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R, Sugimoto K. Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia. Curr Eye Res. 2017;42: 713–720. https://doi.org/10.1080/02713683.2016.1221979
33. Czajkowski J. Myopia – The Epidemic of the 21st Century. Górnicki Medical Publishing, Wrocław, 2021. Polish
34. Dong J, Zhu Z, Xu H, He M. Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial. Ophthalmology. 2023;130(2):198-204 https://doi.org/10.1016/j.ophtha.2022.08.024
35. Xiong F, Mao T, Liao H, Hu X, Shang L, Yu L, et al. Orthokeratology and Low-Intensity Laser Therapy for Slowing the Progression of Myopia in Children. Biomed Res Int. 2021 Jan 27;2021:8915867. https://doi.org/10.1155/2021/8915867
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marcelina Szewczyk, Julia Ufnal, Dominika Rosińska-Lewandoska, Dominika Lewandowska, Klaudia Kożuchowska, Dawid Pilarz, Maria Morawska, Anna Wolff, Szymon Gruszka, Kinga Jarosz

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 101
Number of citations: 0